BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1478199)

  • 1. 7-Chlorokynurenic acid antagonizes the anticonvulsant activity of D-cycloserine in maximal electroshock seizures.
    Peterson SL
    Epilepsy Res; 1992 Oct; 13(1):73-81. PubMed ID: 1478199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of an anatomic substrate for the anticonvulsant activity induced by D-cycloserine.
    Peterson SL
    Epilepsia; 1994; 35(5):933-8. PubMed ID: 7925164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonvulsant drug potentiation by glycine in maximal electroshock seizures is mimicked by D-serine and antagonized by 7-chlorokynurenic acid.
    Peterson SL
    Eur J Pharmacol; 1991 Jul; 199(3):341-8. PubMed ID: 1655484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diazepam potentiation by glycine in pentylenetetrazol seizures is antagonized by 7-chlorokynurenic acid.
    Peterson SL
    Pharmacol Biochem Behav; 1994 Feb; 47(2):241-6. PubMed ID: 8146214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infusion of NMDA antagonists into the nucleus reticularis pontis oralis inhibits the maximal electroshock seizure response.
    Peterson SL
    Brain Res; 1995 Dec; 702(1-2):101-9. PubMed ID: 8846064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some central effects of kynurenic acid, 7-chlorokynurenic acid and 5,7- dichloro-kynurenic acid, glycine site antagonists.
    Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
    Pol J Pharmacol; 1994; 46(3):115-24. PubMed ID: 8000442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of glycine on the anticonvulsant activity of D-cycloserine and L-701,324 in mice.
    Wlaź P; Poleszak E
    Pharmacol Rep; 2011; 63(5):1231-4. PubMed ID: 22180366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiepileptogenic action of 7-chlorokynurenic acid on amygdala kindling of rats.
    Namba T; Morimoto K; Yamada N; Otsuki S
    Pharmacol Biochem Behav; 1993 Oct; 46(2):275-81. PubMed ID: 8265681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-convulsant and adverse effects of the glycineB receptor ligands, D-cycloserine and L-701,324: comparison with competitive and non-competitive N-methyl-D-aspartate receptor antagonists.
    Wlaź P
    Brain Res Bull; 1998 Aug; 46(6):535-40. PubMed ID: 9744291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the glycine/NMDA receptor partial agonist, D-cycloserine, on seizure threshold and some pharmacodynamic effects of MK-801 in mice.
    Wlaź P; Baran H; Löscher W
    Eur J Pharmacol; 1994 May; 257(3):217-25. PubMed ID: 8088343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecally administered D-cycloserine produces nociceptive behavior through the activation of N-methyl-D-aspartate receptor ion-channel complex acting on the glycine recognition site.
    Tan-No K; Esashi A; Nakagawasai O; Niijima F; Furuta S; Sato T; Satoh S; Yasuhara H; Tadano T
    J Pharmacol Sci; 2007 May; 104(1):39-45. PubMed ID: 17452810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats.
    Löscher W; Wlaź P; Rundfeldt C; Baran H; Hönack D
    Br J Pharmacol; 1994 May; 112(1):97-106. PubMed ID: 8032669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anticonvulsant activity of D-cycloserine is specific for tonic convulsions.
    Peterson SL; Schwade ND
    Epilepsy Res; 1993 Jun; 15(2):141-8. PubMed ID: 8370351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice.
    De Sarro G; Ongini E; Bertorelli R; Aguglia U; De Sarro A
    Eur J Pharmacol; 1994 Sep; 262(1-2):11-9. PubMed ID: 7529182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticonvulsant activity of antagonists and partial agonists for the NMDA receptor-associated glycine site in the kindling model of epilepsy.
    Rundfeldt C; Wlaź P; Löscher W
    Brain Res; 1994 Aug; 653(1-2):125-30. PubMed ID: 7982045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of feeding by 7-chlorokynurenic acid, a strychnine-insensitive glycine binding site antagonist.
    Sorrels TL; Bostock E
    Brain Res; 1992 Feb; 572(1-2):265-8. PubMed ID: 1319272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glycine/NMDA receptor partial agonist D-cycloserine blocks kainate-induced seizures in rats. Comparison with MK-801 and diazepam.
    Baran H; Löscher W; Mevissen M
    Brain Res; 1994 Aug; 652(2):195-200. PubMed ID: 7953730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of D-cycloserine on the anticonvulsant activity of phenytoin and carbamazepine against electroconvulsions in mice.
    Wlaź P; Roliński Z; Czuczwar SJ
    Epilepsia; 1996 Jul; 37(7):610-7. PubMed ID: 8681892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of seizure susceptibility in the mouse by the strychnine-insensitive glycine recognition site of the NMDA receptor/ion channel complex.
    Singh L; Oles RJ; Tricklebank MD
    Br J Pharmacol; 1990 Feb; 99(2):285-8. PubMed ID: 1691674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex.
    Bristow LJ; Hutson PH; Kulagowski JJ; Leeson PD; Matheson S; Murray F; Rathbone D; Saywell KL; Thorn L; Watt AP; Tricklebank MD
    J Pharmacol Exp Ther; 1996 Nov; 279(2):492-501. PubMed ID: 8930150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.